Ahles TA, Saykin AJ (2002). Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 3(3): 84–90.
Ahles TA, Saykin AJ (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Rev 7(3): 192–201.
Ahles TA, Saykin AJ, et al
. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20(2): 485–493.
Ahles TA, Silberfarb PM, et al
. (1998). Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. J Clin Oncol 16(5): 1954–60.
Allen JC, Rosen G, et al
. (1980). Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64(12): 1261–73.
Anderson-Hanley C, Sherman ML, et al
. (2003). Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9(7): 967–982.
Ashburner J, Friston KF (2000). Voxel-based morphometry – the methods. NeuroImage 11(6 Pt 1): 805–821.
Ashburner J, Friston KJ (2001). Why voxel-based morphometry should be used. NeuroImage 14(6): 1238–1243.
Bandettini PA, Jesmanowicz A, et al
. (1993). Processing strategies for time-course data sets in functional MRI of the human brain. Magn Res Med 30(2): 161–173.
Bandettini PA, Wong EC (1997). Magnetic resonance imaging of human brain function. Principles, practicalities, and possibilities. Neurosurg Clin North Am 8(3):345–371.
Basser PJ, Mattiello J, et al
. (1994). MR diffusion tensor spectroscopy and imaging. Biophys J 66(1): 259–267.
Belliveau JW, Kwong KK, et al
. (1992). Magnetic resonance imaging mapping of brain function. Human visual cortex. Invest Radiol 27(Suppl 2): S59–S65.
Brezden CB, Phillips KA, et al
. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18(14): 2695–2701.
Brown MS, Simon JH, et al
. (1995). MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma. AJNR Am J Neuroradiol 16(10): 2013–2020.
Brown MS, Stemmer SM, et al
. (1998). White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol 19(2): 217–221.
Castellon SA, Ganz PA, et al
. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 26(7): 955–969.
Castellon SA, Silverman DHS, et al
. (2005). Breast cancer treatment and cognitive functioning: current status and future challenges in assessment. Breast Cancer Res Treat 92(3): 199–206.
Ciesielski KT, Lesnik PG, et al
. (1999). MRI morphometry of mammillary bodies, caudate nuclei, and prefrontal cortices after chemotherapy for childhood leukemia: multivariate models of early and late developing memory subsystems. Behav Neurosci 113(3): 439–450.
D'Esposito M, Zarahn E, et al
. (1999). The effect of normal aging on the coupling of neural activity to the bold hemodynamic response. NeuroImage 10(1): 6–14.
Donovan KA, Small BJ, et al
. (2005). Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma. Cancer 104(11):2499–2507.
Ebner F, Ranner G, et al
. (1989). MR findings in methotrexate-induced CNS abnormalities. Am J Roentgenol 153(6): 1283–1288.
Eichbaum MHR, Schneeweiss A, et al
. (2007). Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109(1): 146–156.
Ferguson RJ, Ahles TA (2003). Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. Curr Neurol Neurosci Rep 3: 215–222.
Ferguson RJ, McDonald BC, et al
. (2007). Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25(25): 3866–3870.
Fritsch G, Urban C (1984). Transient encephalopathy during the late course of treatment with high-dose methotrexate. Cancer 53(9): 1849–1851.
Glass JP, Lee YY, et al
. (1986). Treatment-related leukoencephalopathy. A study of three cases and literature review. Medicine 65(3): 154–162.
Good CD, Johnsrude IS, et al
. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14: 21–36.
Harila-Saari AH, Paakko EL, et al
. (1998). A longitudinal magnetic resonance imaging study of the brain in survivors in childhood acute lymphoblastic leukemia. Cancer 83(12): 2608–2617.
Heflin LH, Meyerowitz BE, et al
. (2005). Re: Cancer as a risk factor for dementia: a house built on shifting sand. J Nat Cancer Inst 97(20): 1550–1551.
Hook CC, Kimmel DW, et al
. (1992). Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 31(3): 262–267.
Inagaki M, Yoshikawa E, et al
. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 109(1): 146–156.
Jenkins V, Shilling V, et al
. (2006). A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94(6): 828–834.
Johnson SC, Saykin AJ, et al
. (2001). Similarities and differences in semantic and phonological processing with age: patterns of functional MRI activation. Aging, Neuropsychol Cogn 8(4): 307–320.
Kanard A, Frytak S, et al
. (2004). Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol 2(2): 127–132.
Kimmel DW, Wijdicks EF, et al
. (1995). Multifocal inflammatory leukoencephalopathy associated with levamisole therapy. Neurology 45(2): 374–376.
Kingma A, van Dommelens RI, et al
. (2001). Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only. J Pediatr 139(3): 413–420.
Klunk WE, Engler H, et al
. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55(3): 306–319.
Komaki R, Meyers CA, et al
. (1995). Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol, Biol Physics 33(1): 179–182.
Kwong KK, Belliveau JW, et al
. (1992). Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Nat Acad Sci USA 89(12): 5675–5679.
Lai S, Hopkins AL, et al
. (1993). Identification of vascular structures as a major source of signal contrast in high resolution 2D and 3D functional activation imaging of the motor cortex at 1.5T: preliminary results. Magn Reson Imaging Med 30: 387–392.
Le Bihan D, Mangin JF, et al
. (2001). Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13(4): 534–546.
Lesnik PG, Ciesielski KT, et al
. (1998). Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model. Arch Neurol 55(12): 1561–1568.
Lien HH, Blomlie V, et al
. (1991). Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate. Radiology 179(2): 547–550.
Logothetis NK, Pauls J, et al
. (2001). Neurophysiological investigation of the basis of the fMRI signal. Nature 412: 150–157.
Mazziotta JC, Toga AW, et al
. (2000). Brain Mapping: The Disorders. San Diego, CA: Academic Press.
McAllister TW, Sparling MB, et al
. (2001). Differential working memory load effects after mild traumatic brain injury. NeuroImage 14(5): 1004–1012.
Meyers CA, Albitar M, et al
. (2005). Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104(4): 788–793.
Meyers CA, Byrne KS, et al
. (1995). Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 12(3): 231–235.
Moonen CTW, Bandettini PA (eds.) (2000). Functional MRI. Berlin: Springer.
Ogawa S, Menon RS, et al
. (1998). On the characteristics of functional magnetic resonance imaging of the brain. Annu Rev Biophys Biomol Struct 27: 447–474.
Packer RJ, Grossman RI, et al
. (1983). High dose systemic methotrexate-associated acute neurologic dysfunction. Med Pediatr Oncol 11(3): 159–161.
Pierpaoli C, Jezzard P, et al
. (1996). Diffusion tensor MR imaging of the human brain. Radiology 201(3): 637–648.
Reddick WE, Laningham FH, Glass JO, Pui CH (2007). Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia. Neuroradiology 49: 889–904.
Reddick WE, Shan ZY, et al
. (2006). Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 106(4): 941–949.
Rosen BR, Buckner RL, et al
. (1998). Event-related functional MRI: past, present, and future. Proc Natl Acad Sci USA 95(3): 773–780.
Ross MH, Yurgelun-Todd DA, et al
. (1997). Age-related reduction in functional MRI response to photic stimulation. Neurology 48(1): 173–176.
Saykin AJ, Ahles TA, et al
. (2003a). Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8(4): 201–216.
Saykin AJ, Ahles TA, et al
. (2003b). Gray matter reduction on voxel-based morphometry in chemotherapy-treated cancer survivors. J Int Neuropsychol Soc 9: 246.
Saykin AJ, McDonald BC, et al
. (2007). Alterations in Brain Activation during Working Memory in Patients with Breast Cancer: Relation to Treatment Modality, Cancer Status and Task Performance
. Available on CD-Rom in NeuroImage, Chicago, IL.
Saykin AJ, Wishart HA, et al
. (2004). Cholinergic enhancement of frontal lobe activity in Mild Cognitive Impairment. Brain 127(7): 1574–1583.
Schagen SB, van Dam FSAM, et al
. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85(3): 640–650.
Shilling V, Jenkins V, et al
. (2005). The effects of adjuvant chemotherapy on cognition in women with breast cancer – preliminary results of an observational longitudinal study. The Breast 14: 142–150.
Silverman DHS, Dy CJ, et al
. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. Breast Cancer Res Treat 103
(3): 303– 311.
Stemmer S, Stears J, et al
. (1994). White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support. Am J Neuroradiol 15(7): 1267–1273.
Tannock IF, Ahles TA, et al
. (2004). Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol 22(11): 2233–2239.
Tchen N, Juffs HG, et al
. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 21(22): 4175–4183.
Toga AW, Mazziotta JC (1996). Brain Mapping: The Methods. San Diego, CA: Academic Press.
Van Dam FSAM, Schagen SB, et al
. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Nat Cancer Inst 90(3): 210–218.
Van Oosterhout AG, Ganzevles PG, et al
. (1996). Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Physics 34(5): 1037–1044.
Wagner L, Sweet J, et al
. (2006). Trajectory of cognitive impairment during breast cancer treatment: a prospective analysis. J Clin Oncol Suppl 24: 8500.
Wagner LI, Sweet JJ, et al
. (2004). Performance of Cognitively Impaired Oncology Patients and Normal Controls on Functional MRI Tasks. American Society of Clinical Oncology Annual Meeting, New Orleans, LA.
Wefel JS, Lenzi R, et al
. (2004a). “Chemobrain” in breast carcinoma?: a prologue. Cancer 101(3): 466–475.
Wefel JS, Lenzi R, et al
. (2004b). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 100: 2292–2299.
Werring DJ, Clark CA, et al
. (1998). The structural and functional mechanisms of motor recovery: complementary use of diffusion tensor and functional magnetic resonance imaging in traumatic injury of the internal capsule. J Neurol Neurosurg Psychiatry 65: 863–869.
Werring DJ, Clark CA, et al
. (1999). A direct demonstration of both structure and function in the visual system: combining diffusion tensor imaging with functional magnetic resonance imaging. NeuroImage 9(3): 352–361.
Wieneke MH, Dienst ER (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 4: 61–66.
Wishart HA, Saykin AJ, et al
. (2004). Brain activation patterns associated with working memory in relapsing-remitting MS. Neurology 62: 234–238.
Yoshikawa E, Matsuoka Y, et al
. (2005). No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat 92(1): 81–84.